Clinical trials: Japan’s opt-out policy raises risks of adverse drug responses Mira Namba,Yudai Kaneda,Akihiko Ozaki,Tetsuya TanimotoNature(2024)引用 0|浏览1暂无评分摘要Letter to the Editor更多查看译文AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要